PROCESS FOR PREPARING IMATINIB AND SALTS THEREOF, FREE OF GENOTOXIC IMPURITY F
The invention relates to an improved process for the preparation of Imatinib and salts thereof, in particular Imatinib Mesylate, having a content of a particular genotoxic impurity, named impurity F, within the pharmacopeia limits.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
22.10.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to an improved process for the preparation of Imatinib and salts thereof, in particular Imatinib Mesylate, having a content of a particular genotoxic impurity, named impurity F, within the pharmacopeia limits. |
---|---|
Bibliography: | Application Number: US201514619542 |